Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma's Emerging Innovation Power
BERLIN, Oct. 20, 2025 /PRNewswire/ -- From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology and pharmaceutical innovation. Representing China's...
China International College Students' Innovation Competition 2025 Finals Conclude in Zhengzhou
ZHENGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- In a report published by Xinhua News Agency, the finals of the China International College Students' Innovation Competition 2025 were held in Zhengzhou from October 13 to 15. Co-organized by the...
3M at China Wind Power 2025: innovations empowering the future of green energy
BEIJING, Oct. 20, 2025 /PRNewswire/ -- On October 20, 2025, 3M, a global leader in diversified technology, made its appearance at the 2025 China Wind Power (CWP 2025). At this year's exhibition, 3M's booth theme was "With Wind as Wings, 3M Empowers...
From Corporate Social Responsibility To Global Consensus: Chery's "Ride Green Life" Unites the World for a Sustainable Future
WUHU, China, Oct. 20, 2025 /PRNewswire/ -- As the global automotive industry accelerates toward a green, low-carbon future, corporate social responsibility has evolved — now defined by sustainable practices fostering harmony between people, society,...
Agoda Spotlights Unique Asian Airports Redefining the Layover Experience
SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Digital travel platform Agoda has unveiled a list of five airports in Asia that transform layovers into memorable experiences. These airports offer more than just transit, with attractions that cater to both...
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances...
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, Results from a Phase 3 study of...
MILESEEY GenePro G1 Named to TIME's "The Best Inventions of 2025: Special Mentions"
The first "GPS + Laser" hybrid rangefinder redefining how golfers see and play the game. CITY OF INDUSTRY, Calif., Oct. 20, 2025 /PRNewswire/ -- MILESEEY Golf proudly announces that its groundbreaking hybrid rangefinder, the GenePro G1, has been...